Bone Biologics BBLG
NASDAQ BBLG
$0.49 -0.01 (-1.90%)
As of: Sep 30, 2026 · 2:06 PM EDT

Bone Biologics Corp (BBLG) Short term Debt (2014 - 2017)

Updated

Bone Biologics' Short term Debt was $12.9 million in Q3 2017, up 43.3% from $9 million a year earlier and up 5.7% from the prior quarter.

Analysis

Bone Biologics Corp (BBLG) Short term Debt (2014 - 2017) Analysis & Trends

At the end of FY2016, Short term Debt at Bone Biologics came in at $10.2 million, up 45.7% from FY2015.

  • In earlier years, Short term Debt was $7 million in FY2015 (+40.0%) and $5 million in FY2014.
  • The Q3 2017 figure marks the highest quarterly Short term Debt in data going back to Q4 2014.
  • Compared with a year earlier, Short term Debt has increased for six straight quarters, with growth averaging 36.8% over the last seven quarters.
  • Per Business Quant data, BBLG's Short term Debt in the three quarters before Q3 2017 was $12.2 million (Q2 2017), $12.2 million (Q1 2017) and $10.2 million (Q4 2016).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 12.90 Mn
Jun 30, 2017 12.20 Mn
Mar 31, 2017 12.20 Mn
Dec 31, 2016 10.20 Mn
Sep 30, 2016 9.00 Mn
Jun 30, 2016 9.00 Mn
Mar 31, 2016 9.00 Mn
Dec 31, 2015 7.00 Mn
Sep 30, 2015 7.00 Mn
Jun 30, 2015 7.00 Mn
Dec 31, 2014 5.00 Mn
API Access

Bone Biologics Corp Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BBLG&period=max&api_key=YOUR_API_KEY